Market Overview

NuVasive to Release $62.5M from Escrow Following Appeals Court Win

Share:
Related NUVA
NuVasive Announces Acquisition Of Ellipse Technologies, Notes 'Potential To Become The Standard Of Care'
Benzinga's Top Upgrades

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today the release of $62.5 million from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision(R) trade name.

Posted-In: News Legal

 

Related Articles (NUVA)

View Comments and Join the Discussion!

Get Benzinga's Newsletters